Healthcare - Biotechnology - NASDAQ - US
$ 1.32
-6.38 %
$ 1.86 M
Market Cap
-0.13
P/E
BALANCE SHEET
11.9 M
ASSETS
14.6 M
LIABILITIES
-2.75 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Allarity Therapeutics, Inc.
| Current Assets | 1.97 M |
| Cash & Short-Term Investments | 166 K |
| Receivables | 946 K |
| Other Current Assets | 859 K |
| Non-Current Assets | 9.89 M |
| Long-Term Investments | 0 |
| PP&E | 20 K |
| Other Non-Current Assets | 9.87 M |
| Current Liabilities | 14.2 M |
| Accounts Payable | 8.42 M |
| Short-Term Debt | 1.3 M |
| Other Current Liabilities | 4.45 M |
| Non-Current Liabilities | 446 K |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 446 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 0.2 | 2.0 | 19.6 | 0.3 | 1.5 |
| Short Term Investments | 0 | 0 | 0.3 | 0 | 0 |
| Receivables | 0.9 | 0.9 | 1.3 | 1.1 | 1.7 |
| Inventory | 0 | 0 | (1.3) | 0 | 2 K |
| Other Current Assets | 0.8 | 2.1 | 36 K | 0.2 | 77 K |
| Total Current Assets | 2.0 | 5.0 | 21.1 | 1.7 | 3.3 |
| PP&E | 20 K | 27 K | 94 K | 0.4 | 0.4 |
| Intangible Assets | 9.9 | 9.5 | 28.1 | 30.5 | 27.7 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0.3 | 0.8 | 0.1 |
| Other Long Term Assets | 0 | 0 | 0.3 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 11.9 | 14.5 | 49.6 | 33.4 | 31.6 |
| LIABILITIES | |||||
| Accounts Payable | 8.4 | 6.3 | 0.7 | 2.1 | 2.2 |
| Short Term Debt | 1.3 | 2.7 | 0.2 | 1.5 | 0.6 |
| Other Current Liabilities | 4.4 | 2.3 | 19.8 | 1.8 | 1.9 |
| Total Current Liabilities | 14.2 | 11.2 | 20.7 | 5.5 | 4.7 |
| Long Term Debt | 0 | 1.1 | 1.0 | 1.1 | 0.3 |
| Deferred Tax Income | 0.4 | 0.3 | 2.0 | 0.6 | 1.9 |
| Other Liabilities | 0 | 0 | 7.2 | (2.3) | 3.8 |
| Total Liabilities | 14.6 | 12.7 | 30.8 | 6.6 | 10.7 |
| EQUITY | |||||
| Common Stock | 0 | 2 K | 0.8 | 1.6 | 0.9 |
| Retained Earnings | (94.5) | (82.5) | (66.5) | (37.4) | (32.4) |
| Other Accumulative Comprehensive Income/Loss | (0.4) | (0.7) | (0.6) | 1.4 | (1.1) |
| Total Equity | (2.8) | 1.9 | 18.8 | 26.9 | 20.9 |
| Total Liabilities and Equity | 11.9 | 14.5 | 49.6 | 33.4 | 31.6 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 99.5 K | 340 | 227 | 117 | 2.26 K |